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1.  page 28.  Table 1
2.  page 28.  Line 27 from the top,  in the right column.
Error:
older),  tumor stage (Tis,  Ta or T1 vs.  T2-T4),
Correction:
older),  tumor stage (pTis,  pTa,  pT1 or pT2 vs.  
pT3-4),
3.  page 29.  Line 2-5 from the top,  in the left column.
Error:
221 patients,  42 (19.2ｵ) died of metastatic urothe-
lial cancer.  The 5-year over all survival was 62.3ｵ.  
Bladder tumor recurrence occurred in 91 patients 
(41.1ｵ).
Correction:
221 patients,  42 (19.0ｵ) died of metastatic urothe-
lial cancer.  The 5-year over all survival was 62.3ｵ.  
Bladder tumor recurrence occurred in 91 patients 
(41.2ｵ).
4.  page 29.  Line 2-3 from the top,  in the right column.
Error:
each classified into 2 subgroups: pTa,  pTis or pT1 
versus pT2-4 and G1 or G2 versus G3,  respec-
tively.
Correction:
each classified into 2 subgroups: pTa,  pTis,  pT1 or 
pT2 versus pT3-4 and G1 or G2 versus G3,  respec-
tively.
5.  page 29.  Fig.  1
　Error:
　Correction:
6.  page 29.  Fig.  1 legend
Error:
Kaplan-Meier disease-specific survival curves for 
patients with stage pTa,  pTis or pT1 and pT2-4 are 
statistically distinct.  (p＜0.0001,  Log-rank test)
　In the article by Kobayashi Y et al.  entitled “Prognostic Factors Inﬂuencing Survival after 
Nephroureterectomy for Transitional Cell Carcinoma of the Upper Urinary Tract” ,  which appeared in the 
February 2010 issue,  Vol. 64,  No. 1,  pp27-31,  following corrections should be listed.
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Error:
　Pathologic Stage (%)
　　pTa 21 (10)
　　pT1 58 (27.5)
　　pT2 22 (10.4)
　　pT3 96 (45.5)
　　pT4  7 (3.3)
　　pTis  7 (3.3)
Correction:
　Pathologic Stage (%)
　　pTa 31 (14.0)
　　pT1 58 (26.2)
　　pT2 22 (10.0)
　　pT3 96 (43.4)
　　pT4  7 (3.2)
　　pTis  7 (3.2)
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Correction:
Kaplan-Meier disease-specific survival curves for 
patients with stage pTa,  pTis,  pT1 or pT2 and 
pT3-4 are statistically distinct.  (p＜0.0001,  Log-
rank test)
7.  page 29.  Fig.  2 legend
Error:
Kaplan-Meier disease-specific survival curves for 
patients with tumor garde 1 or 2 and G3 are statisti-
cally distinct.  (p＜0.0324,  Log-rank test)
Correction:
Kaplan-Meier disease-specific survival curves for 
patients with tumor grade 1 or 2 and G3 are statisti-
cally distinct.  (p＝0.0324,  Log-rank test)
8.  page 30.  Fig.  3
　Error:
　Correction:
9.  page 30.  Table 2
10.  page 30.  Line 1-6 from the top,  in the right column.
Error:
Venous invasion was present in 73 patients (33.3ｵ).  
Eleven (9.3ｵ) of 113 T1 stage patients were posi-
tive,  and 62 (60.2ｵ) of 103 T3 stage patients were 
positive.  In tumor grade,  2 (9ｵ) of 18 G1 patients 
were positive,  22 (18.8ｵ) of 117 G2 patients were 
positive and 49 (56.9ｵ) of 86 G3
Correction:
Venous invasion was present in 73 patients (33.0ｵ).  
Eleven (9.3ｵ) of 118 pTis-pT2 stage patients were 
positive,  and 62 (60.2ｵ) of 103 pT3-4 stage patients 
were positive.  In tumor grade,  2 (11.1ｵ) of 18 G1 
patients were positive,  22 (18.8ｵ) of 117 G2 
patients were positive and 49 (57.0ｵ) of 86 G3
11.  page 31.  Line 1-3 from the top,  in the left column.
Error:
(50ｵ) of 73 patients.  Lymph node metastasis 
occurred in 37 patients (28.7ｵ),  distant metastasis 
occurred in 19 patients (26ｵ) and local recurrence
Correction:
(50.7ｵ) of 73 patients.  Lymph node metastasis 
occurred in 21 patients (28.8ｵ),  distant metastasis 
occurred in 19 patients (26.0ｵ) and local recurrence
12.  page 31.  Line 33 from the top,  in the left column.
Error:
detected in 33.3ｵ of cases in our series,  It was
Correction:
detected in 33.0 ｵ of cases in our series,  It was
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Error:
　Pathologic stage
　　Tis, pTa or pT1 118
　　T2-4 103
　Tumor grade
　　G1 or G2 135
　　G3  68
Correction:
　Pathologic stage
　　pTis, pTa, pT1 or pT2 118
　　pT3-4 103
　Tumor grade
　　G1 or G2 135
　　G3  86
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We analyzed the prognostic factors inﬂuencing survival after surgeries for upper urinary tract 
urothelial carcinoma (UUT-UC) with longer follow-up periods than in previous studies.  Between 
January 2000 and December 2004,  386 patients underwent nephroureterectomy for UUT-UC.  The data 
for the 221 patients with UUT-UC were retrospectively reviewed.  Nine variables were evaluated for 
association with the survival outcomes of disease-speciﬁc survival.  The prognostic signiﬁcance was 
tested univariately with the log-rank test.  The simultaneous eﬀects of multiple prognostic factors were 
estimated by multiple regression analysis using the Cox proportional hazards model.  The median fol-
low-up was 38.4 months.  The 5-year over all survival was 62.3ｵ.  Signiﬁcant prognostic factors for 
disease-speciﬁc survival rate on univariate analysis were pathological stage (p＜0.0001),  tumor grade 
(p＝0.0324),  and venous invasion (p＜0.0001).  Multivariate analysis revealed that only venous invasion 
was signiﬁcant for disease-speciﬁc survival rate (p＝0.0205).  Venous invasion was the only independent 
prognostic factor in pathologically localized UUT-UC.
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pen radical nephroureterectomy (ONU) with 
excision of a bladder cuﬀ has been the gold 
standard of treatment for upper urinary tract urothe-
lial cancer (UUT-UC).  Recently,  this concept has been 
challenged due to the development of more advanced 
techniques for diagnosis,  surgery,  and follow-up.  
Minimally invasive procedures are gaining acceptance 
with regard to laparoscopic radical nephroureterec-
tomy (LNU) [1-3].  We have already revealed that 
LNU does not negatively aﬀect oncological control by 
a comparative multi-institute study enrolling a rela-
tively large number of patients with UUT-UC and 
without prior or concomitant bladder cancer [4,  5].  
Although the survival data suggested that the clinical 
progression reﬂected the cancer stage of the initial 
disease and not the surgical procedure,  the follow-up 
periods in LNU might have been too short to conﬁrm 
this conclusion.
　 In the current study,  we reveal the prognostic fac-
tors inﬂuencing survival and urinary bladder recur-
rence after surgeries for UUT-UC with longer follow-
up periods than in previous studies.
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Materials and Methods
　 A total of 386 patients underwent nephroureterec-
tomy for upper tract transitional cell carcinoma 
between January 2000 and December 2004 in 
Okayama University Hospital and 17 related hospitals.  
Patients with a previous history of bladder cancer,  
with concomitant bladder cancer and with metastasis 
were excluded from the analysis.  The clinicopatho-
logic data for the remaining 221 patients with upper 
tract transitional cell carcinoma were retrospectively 
reviewed.  Upper urinary tract TCC was diagnosed by 
intravenous urography,  retrograde pyelography,  
computed tomography of the abdomen,  magnetic reso-
nance imaging,  and ureteroscopy with or without 
biopsy.  In all patients,  preoperative cystoscopy and 
radiologic examinations were performed to rule out 
metastasis and concomitant bladder tumors.  Patient 
characteristics are given in Table 1.
　 ONU (n＝163) was performed with a broad median 
incision or with lumbar and lower pararectal abdomi-
nal incisions.  LNU (n＝58) was performed using ret-
roperitoneoscopy.  The distal ureter,  including the 
intraluminal portion and the ureteral oriﬁce,  was 
removed en bloc by extravesical resection.  Regional 
lymphadenectomy was not performed routinely.  None 
of the patients received neoadjuvant chemotherapy and 
thirty-four patients (15ｵ) received adjuvant chemo-
therapy consisting of various multidrug regimens and 
a varying number of cycles (9 patients received metho-
trexate,  epirubicin,  and cisplatin [MEC]; 25 
patients received methotrexate,  vinblastine,  adriamy-
cin and cisplatin [M-VAC]).  Sixteen other patients 
received oral 5-ﬂuororacil.
　 Cystoscopy was performed every 3 months for 2 
years after nephroureterectomy,  then every 4 months 
from 2 to 3 years,  every 6 months from 3 to 5 years,  
and annually after 5 years.  Urine cytology was exam-
ined at cystoscopy.  Intravenous urography,  computed 
tomography,  and chest radiography were performed 
annually.
　 Disease-speciﬁc survival from time of surgery was 
deﬁned as the end point for this retrospective analysis.  
Distribution of event times was calculated for each of 
the prognostic factors by Kaplan-Meier.  The following 
variables were evaluated for association with the 
survival outcomes of disease-speciﬁc survival: sex 
(male vs.  female),  age (younger than 70 vs.  70 or 
older),  tumor stage (pTis,  pTa,  pT1 or pT2 vs.  
pT3-4),  tumor grade (G1 or G2 vs.  G3),  venous inva-
sion (yes vs.  no),  lymphatic invasion (yes vs.  no),  
tumor site (ureter involvement vs.  no ureter involve-
ment),  multifocality (yes vs.  no),  and surgical tech-
nique (laparoscopic vs.  open).  Venous invasion and 
lymphatic invasion was deﬁned by the presence of 
cancer cells in the endothelium.  Immunohistochem-
istry for endothelial cells was not done.  The prognos-
tic signiﬁcance of each variable was tested univari-
ately with the log-rank test.  The simultaneous eﬀects 
of multiple prognostic factors were estimated by mul-
tiple regression analysis using the Cox proportional 
hazards model.  Only factors that had a prognostic 
impact at a signiﬁcance level (p) of 0.05 according to 
the univariate analyses were entered into the multiple 
regression model.  Statistical signiﬁcance in this study 
was set as p＜0.05.
Results
　 The median follow-up after nephroureterectomy 
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Table 1　 Patients characteristics
Meadian age (range) 72 (46-92)
Sex (%)
　　Male 153　(69.2)
　　Female 68　(30.8)
Tumor side (%)
　　Right 116　(52.5)
　　Left 105　(47.5)
Tumor site (%)
　　Pelvicalyceal 110　(49.8)
　　Ureter 111　(50.2)
Tumor number (%)
　　Single 168 　(76)
　　Multiple 53　 (24)
Management of tumors
　　Open 163　(73.8)
　　Laparoscopic 58　(26.2)
Pathologic stage (%)
　　pTa 31　(14.0)
　　pT1 58　(26.2)
　　pT2 22　(10.0)
　　pT3 96　(43.4)
　　pT4 7 　(3.2)
　　pTis 7 　(3.2)
Grade (%)
　　1 18　 (8.1)
　　2 117　(52.9)
　　3 86　(38.9)
was 38.4 months (range 0.8 to 92.2 months).  Of the 
221 patients,  42 (19.0ｵ) died of metastatic urothelial 
cancer.  The 5-year over all survival was 62.3ｵ.  
Bladder tumor recurrence occurred in 91 patients 
(41.2ｵ).
　 Nine clinical and pathologic parameters (sex,  age,  
pathologic stage,  tumor grade,  venous invasion,  lym-
phatic invasion,  surgical technique,  tumor site,  mul-
tifocality) were subjected to univariate analysis to 
determine weather they were statistically signiﬁcant 
predictors of disease-speciﬁc survival.  In the analysis,  
age was reclassiﬁed into 2 subgroups: younger than 
70 vs.  70 or older,  and tumor stage and grade were 
each classiﬁed into 2 subgroups: pTa,  pTis,  pT1 or 
pT2 versus pT3-4 and G1 or G2 versus G3,  respec-
tively.  On univariate analysis,  pathologic stage (Fig.  
1),  tumor grade (Fig.  2),  and venous invasion (Fig.  3) 
were found to be statistically signiﬁcant predictors of 
disease-speciﬁc survival.  Table 2 summarizes the 
univariate analysis of risk factors.  Signiﬁcant prog-
nostic factors for the disease-speciﬁc survival rate on 
univariate analysis were pathological stage (p＜
0.0001),  tumor grade (p＝0.0324),  and venous inva-
sion (p＜0.0001).  Multivariate analysis revealed that 
only venous invasion was signiﬁcant for disease-spe-
ciﬁc survival rate (p＝0.0205) (Table 3).
　 Venous invasion was present in 73 patients 
(33.0ｵ).  Eleven (9.3ｵ) of 118 pTis-pT2 stage 
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Fig. 1　 Kaplan-Meier disease-speciﬁc survival curves for patients with stage pTa,  pTis,  pT1 or pT2 and pT3-4 are statistically distinct.  
(p＜0.0001,  Log-rank test)
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Fig. 2　 Kaplan-Meier disease-speciﬁc survival curves for patients with tumor grade 1 or 2 and G3 are statistically distinct.  (p＝0.0324,  
Log-rank test)
patients were positive,  and 62 (60.2ｵ) of 103 pT3-4 
stage patients were positive.  In tumor grade,  2 
(11.1ｵ) of 18 G1 patients were positive,  22 (18.8ｵ) 
of 117 G2 patients were positive and 49 (57.0ｵ) of 
86 G3 patients were positive.  Recurrence occurred in 
37 (50.7ｵ) of 73 patients.  Lymph node metastasis 
occurred in 21 patients (28.8ｵ),  distant metastasis 
occurred in 19 patients (26.0ｵ) and local recurrence 
occurred in 3 patients (4.1ｵ) (Table 4).  Mean period 
until recurrence was 14.5 months.
30 Acta Med.  Okayama　Vol.  64,  No.  1Kobayashi et al.
Table 2　 Univariate analysis of risk factors for disease-speciﬁc 
survival
Variable No. Pts P value
Sex
　　Male 153 0.3559
　　Female  68
Age
　　Younger than 70  87 0.3274
　　70 or older 134
Pathologic stage
　　pTis, pTa, pT1 or pT2 118 ＜0.0001
　　pT3-4 103
Tumor grade
　　G1 or G2 135 0.0324
　　G3  86
Venous invasion
　　Yes  73 ＜0.0001
　　No 148
Lymphatic invasion
　　Yes  60 0.8995
　　No 161
Surgical technique
　　Open 163 0.6345
　　Laparoscopic  58
Tumor site
　　Ureter involvement 111 0.2905
　　No ureter involvement 110
Multifocality
　　Yes  52 0.7008
　　No 169
Table 3　 Multivariate analysis of risk factors for disease-speciﬁc 
survival
Variable HR 95% CI P value
Age 0.623 0.297-1.306 0.2099
Sex 0.775 0.399-1.509 0.4538
Pathologic stage 0.492 0.181-1.336 0.1639
Tumor grade 1.102 0.491-2.088 0.9734
Venous invasion 3.354 1.205-9.337 0.0205
Lymphatic invasion 0.808 0.392-1.665 0.5628
Surgical technique 1.342 0.641-2.810 0.4354
Tumor site 0.806 0.414-1.569 0.5250
Multifocality 1.135 0.548-2.349 0.7332
Table 4　 Recurrence location of 73 venous invasion positive 
patients
Location of recurrnce No. Pts
Lymph node 21
Lung 5
Liver 8
Bone 6
Local 3
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Fig. 3　 Kaplan-Meier disease-speciﬁc survival curves for patients with venous invasion and without venous invasion are statistically 
distinct.  (p＜0.0001,  Log-rank test)
Discussion
　 Nephroureterectomy is considered the standard 
treatment for UUT-UC.  However,  UUT-UC shows a 
signiﬁcantly high local failure even after radical sur-
gery.  Various prognostic factors inﬂuencing survival 
after nephroureterectomy for UUT-UC have been 
reported by investigators.  However,  in recent years,  
a drastic change in the surgical approach for UUT-UC 
has occurred; that is,  although conventional ONU 
remains a standard therapeutic modality for patients 
with upper urinary tract cancer,  LNU has been 
widely applied to clinical practice with advances in 
laparoscopic technology and surgical skills.  This 
change may inﬂuence the prognosis for UUT-UC,  
including the development of recurrent bladder cancer.  
Only a few studies have reported on prognostic factors 
for UUT-UC in this new era of laparoscopic surgery 
[6,  7].  Our study is one of the larger studies and has 
a longer follow-up than others employing multivariate 
analysis.  Tumor location,  tumor grade and pathologic 
stage have been traditionally documented as major 
prognostic factors in patients with UUT-UC.  In our 
study,  pathologic stage and tumor grade were also 
found to be statistically signiﬁcant predictors of 
cause-specific survival on univariate analysis.  
However,  on multivariate analysis,  venous invasion 
was the only independent prognostic factor in patho-
logically localized UUT-UC.  Venous invasion was 
detected in 33.0ｵ of cases in our series.  It was 
associated with high tumor stage and grade,  and 
proved to be the strongest predictor of poor patient 
outcome.  Therefore,  our results demonstrate that the 
aggressiveness of the pathologically localized 
UUT-UC is better characterized by venous invasion 
than by stage or tumor grade.
　 Whereas comparable observations have been 
reported in some studies employing multivariate analy-
ses and detecting vascular invasion in 25-47ｵ of 
cases [1,  3,  8,  9],  lymph vascular invasion was 
regarded as the strongest prognostic factor in them.
　 Although the clinical value of extended lymph-
adenectomy in localized UUT-UC is still controver-
sial,  further study should be done to reveal the value 
of extended lymphadenectomy by the laparoscopic 
approach.
　 Our study is the largest study that has been evalu-
ated using multivariate analysis.  In the surgical man-
agement of UUT-UC,  laparoscopic nephroureterec-
tomy does not negatively aﬀect long-term oncological 
control and can be an alternative modality.  Venous 
invasion is the only independent prognostic factor in 
pathologically localized UUT-UC.
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